This article was originally published in The Gray Sheet
Executive SummaryFDA's General Hospital and Personal Use Devices Advisory Panel is tentatively scheduled to meet in January 1995 to discuss classification of germicides. Germicides currently are regulated as accessories to the medical devices on which they are used; FDAers have suggested that germicides could be classified separately as Class II devices. Under a memorandum of understanding signed by FDA and the Environmental Protection Agency in June 1993, FDA has jurisdiction over sterilants used on critical and semicritical medical devices, whereas EPA has responsibility for general purpose disinfectants ("The Gray Sheet" June 21, 1993, I&W-5)
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.